 |
Advanced Health & Life Extension |
Custom Search
|
|
|
|
|
Advanced Health & Life Extension |
Custom Search
|
|
|
Beta Glucan ReferencesThese references are associated with the article Beta Blucan Beta Glucan References(1) Fitzpatrick FW, DiCarlo JF. Zymosan. In Annals of the New York Academy of Sciences, V.118., p.233-262.1964. (2) Di Luzio NR: Immunopharmacolo~y of glucan : a broad spectrum enhancer of host defense mechanisms. Trends in Pharmacological Sciences 1983; 4: 344-347. (3) Czop JK, Austen KF: A b-glucan inhibitable receptor on human monocytes: its identity with the phagocytic receptor for particulate activators of the alternative complement pathway. JImmunol 1985; 134: 2588-2593. (4) Goldman R: Characteristics of the b-glucan receptor of murine macrophages. . Exp Cel Res 1988; 174: 481-490. (5) Janusz MJ, Austen KF, Czop JK. Isolation of a yeast heptaglucoside that inhibits monocyte phagocytosis of zymosan particles. The Journal of Immunology 198; 142. (6) Hahn MG, Albersheim P: Host-pathogen interactions. XIV. Isolation and partial characterization of an elicitor from yeast extract. Plant Physiol 197X; 62: 107. (7) Seljelid R, Figenschau Y, Bogwald J, et al. Evidence that tumor necrosis induced by aminated beta 1-3D polyglucose is mediated by a concerted action of local and systemic cytokines. Scand J Immunol. Dec1989;30(6):687-94. (8) Bousquet M, Escoula L, Peuriere S, et al. Immunopharmacologic study in mice of 2 beta-1, 3, beta-1, 6 polysaccharides (scleroglucan and PSAT) on the activation of macrophages and T lymphocytes. Ann Rech Vet. 1989;20(2):165-73. (9) Seljelid R, Figenschau Y, Bogwald J, et al. Evidence that tumor necrosis induced by aminated beta 1-3D polyglucose is mediated by a concerted action of local and systemic cytokines. Scand J Immunol. Dec1989;30(6):687-94. (10) Kougias P, Wei D, Rice PJ, et al. Normal human fibroblasts express pattern recognition receptors for fungal (1-->3)-beta-D-glucans. Infect Immun. Jun2001;69(6):3933-8. (11) Patchen M: Radioprotective effect of Oral Administration of NSC-24™. 1989. ImmuDyne, Inc. Unpublished. (12) Patchen ML, D'Alesandro MM, Brook I, Blakely WF, McVittie TJ: Glucan: mechanisms involved in its "radioprotective" effect.. J Leuc Biol 1987; 42: 95-105. (13) Bell S, Goldman VM, Bistrian BR, et al. Effect of beta-glucan from oats and yeast on serum lipids. Crit Rev Food Sci Nutr 1999;39:189-202 (14) Bell S, Goldman VM, Bistrian BR, et al. Effect of beta-glucan from oats and yeast on serum lipids. Crit Rev Food Sci Nutr 1999;39:189-202 (15) Behall KM, Scholfield DJ, Hallfrisch J. Effect of beta-glucan level in oat fiber extracts on blood lipids in men and women. J Am Coll Nutr 1997;16:46-51. (16) Braaten JT, Wood PJ, Scott FW, et al. Oat beta-glucan reduces blood cholesterol concentration in hypercholesterolemic subjects. Eur J Clin Nutr 1994;48:465-74. (17) Davidson MH, Dugan LD, Burns JH, et al. The hypocholesterolemic effects of beta-glucan in oatmeal and oat bran. A dose-controlled study. JAMA 1991;265:1833-9. (18) Wood PJ. Physicochemical properties and physiological effects of the (1----3)(1----4)-beta-D-glucan from oats. Adv Exp Med Biol 1990;270:119-27. (19) Uusitupa MI, Miettinen TA, Sarkkinen ES, et al. Lathosterol and other non-cholesterol sterols during treatment of hypercholesterolaemia with beta-glucan-rich oat bran. Eur J Clin Nutr 1997;51:607-11. (20) Lia A, Hallmans G, Sandberg AS, et al. Oat beta-glucan increases bile acid excretion and a fiber-rich barley fraction increases cholesterol excretion in ileostomy subjects. Am J Clin Nutr 1995;62:1245-51. (21) Bell S, Goldman VM, Bistrian BR, et al. Effect of beta-glucan from oats and yeast on serum lipids. Crit Rev Food Sci Nutr 1999;39:189-202 (22) Nicolosi R, Bell SJ, Bistrian BR, et al. Plasma lipid changes after supplementation with beta-glucan fiber from yeast. Am J Clin Nutr 1999;70:208-12. (23) Behall KM, Scholfield DJ, Hallfrisch J. Effect of beta-glucan level in oat fiber extracts on blood lipids in men and women. J Am Coll Nutr 1997;16:46-51. (24) Braaten JT, Wood PJ, Scott FW, et al. Oat beta-glucan reduces blood cholesterol concentration in hypercholesterolemic subjects. Eur J Clin Nutr 1994;48:465-74. (25) Uusitupa MI, Ruuskanen E, Makinen E, et al. A controlled study on the effect of beta-glucan-rich oat bran on serum lipids in hypercholesterolemic subjects: relation to apolipoprotein E phenotype. J Am Coll Nutr 1992;11:651-9. (26) Braaten JT, Scott FW, Wood PJ, et al. High beta-glucan oat bran and oat gum reduce postprandial blood glucose and insulin in subjects with and without type 2 diabetes. Diabet Med 1994;11:312-8. (27) Wood PJ. Physicochemical properties and physiological effects of the (1----3)(1----4)-beta-D-glucan from oats. Adv Exp Med Biol 1990;270:119-27. (28) Bourdon I, Yokoyama W, Davis P, et al. Postprandial lipid, glucose, insulin, and cholecystokinin responses in men fed barley pasta enriched with beta-glucan. Am J Clin Nutr 1999;69:55-63. (29) Pick ME, Hawrysh ZJ, Gee MI. Oat bran concentrate bread products improve long-term control of diabetes: a pilot study. J Am Diet Assoc 1996;96:1254-61. (30) Frey A, Giannasca KT, Weltzin R, et al. Role of the glycocalyx in regulating access of microparticles to apical plasma membranes of intestinal epithelial cells: implications for microbial attachment and oral vaccine targeting. J Exp Med. Sep1996;184(3):1045-59. (31) Tsukagoshi S, Hashimoto Y, Fujii G, et al. Krestin (PSK). Cancer Treat Rev. Jun1984;11(2):131-55. (32) Rylander R, Lin RH. (1-->3)-beta-D-glucan - relationship to indoor air-related symptoms, allergy and asthma. Toxicology. Nov 2000;152(1-3):47-52. (33) Rylander R, et al. (1-->3)-beta-D-glucan may contribute to pollen sensitivity. Clin Exp Immunol. Mar 1999;115(3):383-4. (34) The Acute Oral Toxicity Study of NSC-24 in Rats. Essex Testing Clinic. 1990, NJ, USA.
  |
|
